Access to medicines
Imported generics as effective as branded antivirals for hepatitis C
Hepatitis C infection was undetectable in 98% of patients after treatment with generic antivirals.
Source: BSIP SA / Alamy Stock Photo
Access to antiviral therapy for hepatitis C infection is restricted in some countries due to the high cost of branded drugs.
Researchers in Australia, where patients can legally import a three-month supply of treatment, studied the efficacy of imported generic antivirals in 419 patients with hepatitis C infection.
Their interim results show that the virus was undetectable in 98% of patients at the end of treatment, and in 96% of patients four weeks after stopping treatment.
The researchers, who reported their findings at the International Liver Congress in April 2016, said the results are comparable to those seen in phase III trials of branded treatments. They added that improving access to these cheaper generic drugs could therefore have a major impact on hepatitis C treatment around the world.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201038
Recommended from Pharmaceutical Press